The 1 Stock I’m Most Confident Will Double by 2027

When I look at my portfolio, there’s one name that keeps standing out, not just because it’s down, but because it’s misunderstood.
That stock is Oscar Health ($OSCR).

It’s not flashy. It doesn’t dominate headlines. But it’s solving a real problem with real technology and the market hasn’t priced that in yet.

Here’s why I think $OSCR is one of the best setups out there right now.

1. They’re Rebuilding Health Insurance from the Ground Up

Health insurance is one of the most bloated, outdated industries in the country. Oscar isn’t trying to patch the system, they’re rebuilding it entirely. Their mobile-first platform handles everything from signup to claims, all in one place. It’s simple, direct, and actually works.

For consumers, it means less stress and better service. For the company, it means lower overhead, better margins, and scalable tech.

2. They Own Their Tech — and That Matters

Most insurers rely on third-party systems that slow them down and drive up costs. Oscar runs its own backend, powered by AI and automation. This gives them an edge on both cost and experience.

Their platform can process claims, manage patient interactions, and flag issues in real time — things legacy insurers are still years away from doing efficiently.

It’s a health tech company that happens to sell insurance. That’s a huge difference.

3. The Market is Enormous

Oscar is targeting the individual and small group market, which represents tens of millions of Americans. That’s a segment that’s long been underserved, and Oscar is gaining traction by offering a cleaner, more transparent experience.

They also have strategic partnerships in place, including collaborations with health systems and provider networks. These can help them grow while staying capital efficient.

4. They're Getting Smarter With Capital

Early on, Oscar burned cash like most startups. But over the past few quarters, they’ve reigned in spending, improved margins, and narrowed losses. This isn’t just a tech story — it’s a business maturing in real time.

They’re moving toward profitability, not just top-line growth. And with plenty of cash on hand and a manageable burn rate, they don’t seem desperate for outside funding.

That kind of financial discipline matters.

5. The Valuation Makes This a Rare Opportunity

Even if they grow at a moderate pace and achieve a 15–20% margin by 2027, I believe Oscar could easily justify a $30–$33 price target, and that’s using conservative assumptions.

At today's price, that would more than double your money. And unlike some speculative plays, this one is backed by real revenue, a growing customer base, and improving financials.

It’s the kind of setup I love! With strong fundamentals, weak sentiment, and a wide disconnect between price and potential.

6. Everyone Loved It at $20. Now It’s Crickets.

What’s funny is… when $OSCR was trading around $20, it was everywhere. People were calling it the next big disruptor. Now that it’s down ~30%? Crickets.

But nothing has changed in the core story. If anything, they’ve made more progress and are closer to profitability. That disconnect between reality and market sentiment?
That’s the opportunity.

Final Thoughts

I’m not saying Oscar is risk-free. No early-stage disruptor is. But if you’re looking for a long-term play in a broken industry, backed by real tech and smart leadership, this is one worth watching.

To me, $OSCR is the easiest potential 2x in my portfolio by 2027. And if things go right?
It could be much more than that.

This is not financial advice. Please do your own research and speak with a licensed financial professional before making any investment decisions. All investments carry risk, and past performance is not indicative of future results.